MINI FUTURE OPTIONSSCHEIN PUT - AMGEN | Real-time Boerse Frankfurt Warrants 10:04:47 31/05/2024 pm IST | ||
| 10.05 EUR | -1.95% |
|
| Current month | -22.11% | ||
| 1 month | -22.11% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 10.05 | -1.95% |
| 30/24/30 | 10.25 | -5.53% |
| 29/24/29 | 10.85 | +3.24% |
| 28/24/28 | 10.51 | +8.69% |
| 27/24/27 | 9.67 | -1.93% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 10:04 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ7N6S |
| ISIN | DE000DJ7N6S6 |
| Date issued | 15/12/2023 |
| Strike | 411.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 12.16 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.43 € |
|---|---|
| Lowest since issue | 8.01 € |
| Spread | 0.01 € |
| Spread % | 0.10% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
301
USD
Average target price
316.3
USD
Spread / Average Target
+5.07%
- Stock Market
- Certificates
- Certificat
